rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-12-1
|
pubmed:abstractText |
We report a patient with renal insufficiency (creatinine clearance, CL(cr) = 38 mL/min) who received high-dose chemotherapy with cyclophosphamide (1,500 mg/m(2) day(-1)), thiotepa (120 mg/m(2) day(-1)) and carboplatin (AUC = 5 mg min/mL day(-1)) for four consecutive days.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1432-0843
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
375-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:18431571-Adult,
pubmed-meshheading:18431571-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18431571-Carboplatin,
pubmed-meshheading:18431571-Cyclophosphamide,
pubmed-meshheading:18431571-Drug Interactions,
pubmed-meshheading:18431571-Humans,
pubmed-meshheading:18431571-Male,
pubmed-meshheading:18431571-Metabolic Clearance Rate,
pubmed-meshheading:18431571-Renal Insufficiency,
pubmed-meshheading:18431571-Sarcoma, Ewing,
pubmed-meshheading:18431571-Thiotepa
|
pubmed:year |
2009
|
pubmed:articleTitle |
Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiency.
|
pubmed:affiliation |
Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Louwesweg 6, 1066 EC Amsterdam, The Netherlands. corine.ekhart@slz.nl
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|